StockData
Virax Biolabs Group Ltd logo

Virax Biolabs Group Ltd (VRAX) stock

VRAXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 6, 2026Score 9/30
$0.45−0.00 (-0.65%)

Close on Nov 17, 2026Market cap $257.81KP/E –Yield –

Virax Biolabs market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Virax Biolabs's market cap was $363.23K on Nov 11, 2026, against $1.75M a year earlier. Over the last 4 years it ranged from $363.23K to $53.87M, with a median of $3.44M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$363.23K-75.8%
2025Dec 31, 2025$1.50M-74.1%
2024Dec 31, 2024$5.79M+155.1%
2023Dec 29, 2023$2.27M-68.8%
2022Dec 30, 2022$7.28M–

More Virax Biolabs figures

See a number that looks wrong?